These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 34856584)

  • 41. Oncological Outcomes of Transanal Endoscopic Surgery for the Surgical Management of T2 and T3 Rectal Cancer.
    Johnson GGRJ; Robertson RL; Vergis A; Raval M; Phang T; Karimuddin A; Brown C
    Dis Colon Rectum; 2023 Jul; 66(7):1012-1021. PubMed ID: 36876985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Clinicopathological Feature-Based Nomogram for Predicting the Likelihood of D3 Lymph Node Metastasis in Right-Sided Colon Cancer Patients.
    Long C; Feng M; Wang S; Ji H; Li Z; Zheng J; Jiang W; Yan J
    Dis Colon Rectum; 2023 Jan; 66(1):75-86. PubMed ID: 34897214
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transanal Total Mesorectal Excision Versus Anterior Total Mesorectal Excision for Rectal Cancer: A Propensity Score Matched, Population-Based Study in Catalonia, Spain.
    Manchon-Walsh P; de Lacy FB; Pera M; Espin-Basany E; Targarona EM; Biondo S; Aliste Sanchez L; Pallarès N; Tebé C; Pata F; Lacy AM; Guarga A; Borràs JM
    Dis Colon Rectum; 2022 Feb; 65(2):207-217. PubMed ID: 34636779
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High Risk of Low Anterior Resection Syndrome in Long-term Follow-up After Anastomotic Leakage in Anterior Resection for Rectal Cancer.
    Jutesten H; Buchwald PL; Angenete E; Rutegård M; Lydrup ML
    Dis Colon Rectum; 2022 Oct; 65(10):1264-1273. PubMed ID: 35482994
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early Experience With Transanal Total Mesorectal Excision Compared With Laparoscopic Total Mesorectal Excision for Rectal Cancer: A Propensity Score-Matched Analysis.
    Alhanafy MK; Park SS; Park SC; Park B; Kim MJ; Sohn DK; Chang HJ; Oh JH
    Dis Colon Rectum; 2020 Nov; 63(11):1500-1510. PubMed ID: 33044291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A US Rectal Cancer Consortium Study of Inferior Mesenteric Artery Versus Superior Rectal Artery Ligation: How High Do We Need to Go?
    Turgeon MK; Gamboa AC; Regenbogen SE; Holder-Murray J; Abdel-Misih SRZ; Hawkins AT; Silviera ML; Maithel SK; Balch GC
    Dis Colon Rectum; 2021 Oct; 64(10):1198-1211. PubMed ID: 34192711
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does Sarcopenia Predict Local Response Rates After Chemoradiotherapy for Locally Advanced Rectal Cancer?
    Bedrikovetski S; Traeger L; Vather R; Sammour T; Moore JW
    Dis Colon Rectum; 2023 Jul; 66(7):965-972. PubMed ID: 36538702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microbiota DNA Translocation Into Mesentery Lymph Nodes Is Associated With Early Development of Pouchitis After IPAA for Ulcerative Colitis.
    Zhao L; Zhu F; Chen J; Wang Z; Zhang T; Yu Z; Xu Y; Ding C; Gong J
    Dis Colon Rectum; 2023 Nov; 66(11):e1107-e1118. PubMed ID: 36649193
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
    Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low Anterior Resection Syndrome After Transanal Total Mesorectal Excision: A Comparison With the Conventional Top-to-Bottom Approach.
    Foo CC; Kin Ng K; Tsang JS; Siu-Hung Lo O; Wei R; Yip J; Lun Law W
    Dis Colon Rectum; 2020 Apr; 63(4):497-503. PubMed ID: 32015290
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patient Survival With ypT0N+ Following Neoadjuvant Therapy in Rectal Cancer.
    Elshami M; Goldstone RN; Blaszkowsky LS; Cusack JC; Hong TS; Wo JY; Qadan M
    Dis Colon Rectum; 2022 Oct; 65(10):1224-1231. PubMed ID: 35714358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic Value of the Circumferential Resection Margin After Curative Surgery for Rectal Cancer: A Multicenter Propensity Score-Matched Analysis.
    Galvez A; Biondo S; Trenti L; Espin E; Kraft M; Farres R; Codina-Cazador A; Flor B; Garcia-Granero E; Enriquez-Navascues JM; Borda-Arrizabalaga N; Kreisler E
    Dis Colon Rectum; 2023 Jul; 66(7):887-897. PubMed ID: 35348529
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lack of Complete Pretreatment Staging Is Associated With Omission of Neoadjuvant Therapy for Rectal Cancer: A Statewide Study.
    Tang D; Rivard SJ; Weng W; Ramm CA; Cleary RK; Hendren S
    Dis Colon Rectum; 2023 May; 66(5):662-670. PubMed ID: 35195556
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional Outcomes and Quality of Life After Transanal Total Mesorectal Excision for Rectal Cancer: A Prospective Observational Study.
    de Lacy FB; Turrado-Rodriguez V; Torroella A; van Laarhoven J; Otero-Piñeiro A; Almenara R; Lacima G; Castells A; Lacy AM
    Dis Colon Rectum; 2022 Jan; 65(1):46-54. PubMed ID: 34596984
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Uptake of Total Mesorectal Excision and Total Mesorectal Excision Grading for Rectal Cancer: A Statewide Study.
    Kanters AE; Cleary RK; Obi SH; Asgeirsson T; Evilsizer SK; Fasbinder LG; Campbell DA; Hendren SK
    Dis Colon Rectum; 2020 Jan; 63(1):53-59. PubMed ID: 31633602
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Circumferential Resection Margin Status as a Predictive Factor for Recurrence in Preoperative MRI for Advanced Lower Rectal Cancer Without Preoperative Therapy.
    Mazaki J; Tsukamoto S; Miyake M; Moritani K; Sakamoto R; Shida D; Kanemitsu Y
    Dis Colon Rectum; 2021 Jan; 64(1):71-80. PubMed ID: 33306533
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic Impact of Lymphatic Invasion, Venous Invasion, Perineural Invasion, and Tumor Budding in Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy Followed by Total Mesorectal Excision.
    Kim S; Huh JW; Lee WY; Yun SH; Kim HC; Cho YB; Park YA; Shin JK
    Dis Colon Rectum; 2023 Jul; 66(7):905-913. PubMed ID: 35195558
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Prospective Multicenter Phase II Study on the Feasibility and Efficacy of S-1 and Oxaliplatin Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer.
    Sakamoto Y; Morohashi H; Miura T; Tsutsumi S; Takahashi S; Hirama K; Wakiya T; Hakamada K
    Dis Colon Rectum; 2022 May; 65(5):663-671. PubMed ID: 33833145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Longitudinal Analysis of Local Recurrence and Survival After Transanal Abdominal Transanal Radical Proctosigmoidectomy for Low Rectal Cancer Treated With Neoadjuvant Chemoradiation Therapy.
    Marks JH; Reif de Paula T; Saidi H; Ikner TP; Schoonyoung H; Marks G; Keller DS
    Dis Colon Rectum; 2024 Mar; 67(3):377-386. PubMed ID: 38064243
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Omentoplasty in Patients Undergoing Abdominoperineal Resection After Long-Course Chemoradiation for Locally Advanced and Locally Recurrent Rectal Cancer: A Comparative Single-Institution Cohort Study.
    van Campenhout I; van Rees JM; Ceelen W; Tanis PJ; Rothbarth J; Verhoef C
    Dis Colon Rectum; 2023 Jul; 66(7):994-1002. PubMed ID: 36574322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.